Precede Biosciences
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$140.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Precede Biosciences is a biotechnology company that offers a liquid biopsy platform for in-depth analysis of disease-related biology through a simple blood test.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Precede Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Precede Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Debt | Jan 12, 2026 | ||||
| Series A | Oct 5, 2023 |
Key People
Founding team and executive leadership
Precede Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Binney Street Capital | Seed, Series A, Series B |
| Osage University Partners | Series A, Series B |
| 5AM Ventures | Seed, Series B, Series A |
| Alexandria Venture Investments | Series B |
| Mirae Asset Capital Life Science | Series B |
| Mirae Asset Capital | Series B |
| Lilly Asia Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Launched Precede Bio Insight, an epigenomic liquid biopsy platform.
- Apr 17, 2026
Presented new data at the AACR 2026 Annual Meeting.
Precede Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Precede Biosciences's valuation, stock price, and market status.